Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2012.965 mmr-06-03-0639 Articles Variants in the SRD5A2 gene are associated with quality of semen ZHAODAN1* WUWEI23* XUBIN1 NIUXIAOBING1 CUIHONGXING1 ZHANGYI1 WANGZENGJUN1 WANGXINRU23 State Key Laboratory of Reproductive Medicine, Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P.R. China State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing 210029, P.R. China Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 210029, P.R. China Correspondence to: Dr Zengjun Wang, Department of Urology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, P.R. China, E-mail: zengjunwang@njmu.edu.cn

Contributed equally

 9 2012 9 2012 25 06 2012 6 3 639 644 13 02 2012 19 06 2012 Copyright © 2012, Spandidos Publications 2012 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

Spermatogenesis and sperm maturation are androgen-dependent processes. Steroid 5α-reductase (SRD5A) is a key enzyme converting testosterone into the more active metabolite, dihydrotestosterone (DHT). We aimed to investigate the association between the genetic variants of SRD5A2 (rs4952197, rs2268797, rs13395648, rs523349 and rs632148) and semen quality. Variant genotyping and semen analysis was performed in 708 males with definite idiopathic infertility by TaqMan SNP genotyping assays and computer-assisted semen analysis, respectively. It was found that the rs13395648 TC genotype was associated with a significantly lower semen volume compared with the TT genotype (P=0.016). The same trend was found between the combination of the TC and CC genotypes and the TT genotype (P=0.020). With regard to variant rs632148, subjects with the GC genotype had significantly lower sperm motility in comparison to those with the GG genotype (P=0.029). The sperm motility between the combination of the GC and CC genotypes and the GC genotype was also significantly different (P=0.033). These findings indicate that genetic variants in the SRD5A2 gene may be associated with semen quality.

 idiopathic male infertility polymorphism semen quality SRD5A2 Introduction

Infertility has been defined as the failure of a couple to conceive and reproduce after 12 months of regular intercourse (1). Approximately 13–15% of couples of reproductive age worldwide are affected by this common clinical problem, and half of these cases are related to male dysfunction (2). Among all males with infertility, the cause of more than half is unknown (idiopathic). Irregularities in sperm function or spermatogenesis are believed to be associated with idiopathic male infertility (3).

Spermatogenesis and spermatozoa maturation is an androgen-dependent process (4). Dihydrotestosterone (DHT) is the main androgen responsible for spermatozoa maturation (5), as well as for the maintenance of normal spermatogenesis (6). The enzyme steroid 5α-reductase (SRD5A) is a key enzyme involved in converting testosterone into a more potent androgen, DHT, in male reproductive tissues. Human 5α-reductase mainly consists of type 1 (SRD5A1) and type 2 (SRD5A2) isozymes, but type 2 is more essential for development of the male reproductive organs (7) and thus may be associated with semen quality compared with type 1.

The SRD5A2 gene is on chromosome 2p23 with 5 exons, encoding a 254 amino acid protein (7). Several missense polymorphisms affect enzyme activity (8): some normal variations in the SRD5A2 gene may be associated with prostate cancer (9), while other serious mutations of SRD5A2 reduce or eliminate enzymatic activity and cause deficient virilization of the male external genitalia or even pseudohermaphrodism during development (10–12). Of these, three single nucleotide polymorphisms (SNPs) alter other amino acids of SRD5A2 that are more noteworthy. The most common variation is a valine to leucine substitution at codon 89 (V89L, rs523349), which has been associated with prostate cancer. Due to this variation, there is an approximately 30% reduced activity of SRD5A2 in Asian men (13), which is not found in European populations (14–15). The other missense polymorphism is at codon 49, substituting an alanine with a threonine at codon 49 (A49T). The T-variant has mainly been associated with prostate cancer and was shown to increase the enzymatic activity to a great extent (16–17). The R227Q mutation substitutes arginine with glutamine, leading to SRD5A2 enzymatic activity being almost completely absent. With the exception of the above three mutations, other mutations are detected at a very low frequency (8). Nevertheless, all of the above shows that variations of SRD5A2 are associated with an increased risk of developing diseases of the male reproductive organs and functions. Thus, we speculate whether the polymorphisms in the SRD5A2 gene are associated with semen quality in the Han-Chinese population.

In the present study, we investigated the frequency distribution of five tagSNPs representing genetic variation across the entire SRD5A2 gene in 708 patients with idiopathic infertility. This study may add to our knowledge regarding the impact of SRD5A2 polymorphisms on male infertility. The SNP tagging method is used to select tagSNPs. Five tagSNPs were captured to present 648 SNPs of human SRD5A2. Therefore, the purpose of this study was to investigate the possible association between the genetic variants of SRD5A2 and semen quality in 708 males with definite idiopathic infertility in a Han-Chinese population.

 Materials and methods Subjects

A total of 708 ethnic Han-Chinese males with definite idiopathic infertility (without diagnosed infertile wives) visiting the First Affiliated Hospitals of Nanjing Medical University were consecutively recruited between March 2010 and March 2011. All the subjects had been unable to conceive for at least 12 months. Those with a history of orchitis, obstruction, cryptorchidism, congenital bilateral absence of vas deferens, cytogenetic abnormalities and Y chromosome microdeletions were excluded from the study after a complete historical and physical examination (18–19). All participants provided informed consent and completed a questionnaire including information about age, smoking and drinking habits and other lifestyle factors. Each subject donated 5 ml of peripheral blood for genomic DNA extraction and an ejaculate for semen analysis. This study was approved by the ethics review board of Nanjing Medical University.

 Semen analysis

The computer-assisted semen analysis system (WLJY-9000; Weili New Century Science and Tech Dev., Beijing, China) was used to perform the semen analysis according to the World Health Organization guidelines (World Health Organization, 1999). Four parameters of semen quality were selected for the statistical analysis: Semen volume, sperm concentration (106/ml), sperm number per ejaculate (106/ejaculate) and sperm motility. The sperm numbers and sperm motility characteristics provided a reliable estimation of the fertilizing ability of human spermatozoa (20). Strict quality control measures were enforced throughout the study. Each sample was assessed twice.

 SNP selection

Genotype data obtained from unrelated Han Chinese individuals from Beijing in the HapMap (HapMap Data Rel 24/phase II nov08, on NCBI B36 assembly, dbSNP b126; http://hapmap.ncbi.nlm.nih.gov) were used to select the SNPs. SNPs with a minor allele frequency >0.05 in Han Chinese in Beijing were selected within the 56318 bp human SRD5A2 gene, which was pinpointed to chromosome 2 from 31603218 to 31659535. Thirty SNPs were captured in this region. A linkage disequilibrium (LD) plot of this region was made using Haploview 4.0 software (21), based on the r2 values, which indicate the ability of a certain SNP to predict another SNP (Fig. 1). Using Tagger and a tagging threshold of r2>0.80, five tagSNPs were selected (rs4952197, rs2268797, rs13395648, rs523349 and rs632148) that could represent other SNPs of this region with a mean r2 of 0.959 (Fig. 1).

 Genotyping

Genomic DNA was extracted from peripheral blood leukocytes of 708 Han-Chinese males suffering from infertility according to standard protocols (Genomic DNA kit; Tiangen, Beijing, China). TaqMan SNP genotyping assays were performed using the Taq amplification method in a 7900 HT Fast Real-Time PCR system (Applied Biosystems, Foster City, CA, USA).

PCR amplification of rs4952197, rs2268797 and rs13395648 was performed at 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec, 56°C for 10 sec and 60°C for 1 min, with one additional cycle at 60°C for 10 min. The amplification conditions of rs523349 and rs632148 were similar to the above except that 55 cycles were used due to the higher relative GC content. Ten percent of study participants were randomly chosen and genotyped in duplicate to confirm the concordance of the genotyping results. In our study, the call rates for these SNP genotyping were >97% and the concordance of duplicates was 100%.

 Statistical analysis

Logarithmic transformation of the sperm concentration and sperm number per ejaculate was undertaken to achieve homogeneity of variance and normal distribution of residuals. No transformation was performed for the remaining parameters. Differences in selected demographic variables, smoking and alcohol status were evaluated by the χ2 test. The Student’s t-test was used to evaluate continuous variables, including age, BMI and pack-years of cigarette smoking. For statistical analysis, a multiple linear regression analysis was applied for the comparison of semen parameters as considered for the genotypes of each SNP. Statistical analyses were carried out using Stata (Version 9.0, StataCorp, LP). P<0.05 was considered to indicate a statistically significant difference.

 Results Characteristics of the study populations

The study population comprised 708 ethnic Han-Chinese males with definite idiopathic infertility at 30.57±5.14 years of age. The mean duration of sexual abstinence prior to semen collection was 5.23±3.52 days. The sperm parameters between the stratification of selected characteristics were analyzed (Table I). No significant differences were found in the stratification of age, smoking and BMI (body mass index) for all four parameters. However, the sperm number per ejaculate and the sperm motility were significantly higher in the never drinking group when compared with the ever drinking group (P=0.015 and 0.0425, respectively). No significant difference was observed in the remaining parameters (semen volume and concentration) between the ever drinking and never drinking groups. For the duration of sexual abstinence (Abs), the 4–7 days group and ≥7 days group were associated with a significantly higher semen volume (P<0.001 and P<0.001, respectively) and sperm number per ejaculate (P=0.025 and P<0.001, respectively) compared with the <4 days group. The sperm concentration between the ≥7 days group and the <4 days group was also significantly different (P=0.013). The sperm motility parameter among the three stratifications of the duration of sexual abstinence was similar.

 Associations between SRD5A2 SNPs and semen quality

Table II shows the association of the genotype frequency and sperm parameters of each variant. The sperm concentration and sperm number per ejaculate were not significantly different between the genotypes of each genetic variant. The semen volume was also similar among the genotypes of three variants (rs4952197, rs2268797 and rs523349). For rs13395648, the subjects with the TC genotype presented a significantly lower semen volume compared with the TT genotype (P=0.016). The same trend was found between the combination of the TC and CC genotypes and the TT genotype (P=0.020) (Table II).

For rs632148, the GC genotype carriers had a significantly lower motility compared with the GG genotype (P=0.029). However, the difference between the CC and GG genotypes was not statistically significant (P=0.078), whereas the combination of GC and CC genotype carriers had a significantly lower motility compared with the GG genotype (P=0.033) (Table II). The sperm motility was not significantly different between the genotypes of rs4952197, rs2268797, rs13395648 and rs523349 (Table II).

 Discussion

In the present study, five tagSNPs (rs4952197, rs2268797, rs13395648, rs523349 and rs632148) in the SRD5A2 gene were selected using the tagSNP method. In total, 708 Han-Chinese males with idiopathic infertility were genotyped for these SNPs using TaqMan-based genotyping. Significant associations were detected between the genetic variant rs13395648 and semen volume, and between the genetic variant rs632148 and sperm motility. It was demonstrated that subjects with the rs13395648 TC genotype had significantly lower semen volume compared with those with the TT variant. The same trend was also found in subjects carrying a C allele at rs13395648 (TC and CC). Regarding rs632148, the sperm motility was significantly lower in subjects with the GC genotype compared with those with the GG genotype. The combination of GC and CC genotype carriers also had a significantly lower motility compared with the GG genotype. No association was found between any of the remaining three polymorphisms and semen quality.

The sperm number and motility characteristics are known to be the most informative parameters in semen quality analysis and may provide a reliable estimation of the fertilizing ability of human spermatozoa (20), which are dependent on normal spermatogenesis and spermatozoa maturation (2,22). Spermatogenesis and spermatozoa maturation are androgen-dependent processes (4–5,23). SRD5A is a key enzyme converting testosterone into a more potent androgen, DHT. Therefore, the SRD5A enzyme is crucial in these processes. Furthermore, it is more likely that milder polymorphic variations of SRD5A2 are associated with semen quality. In this study, we examined the association of the SRD5A2 gene with semen parameters in 708 Han-Chinese males with definite idiopathic infertility. Results showed that the heterozygote at rs13395648 and rs632148 in SRD5A2 was significantly associated with semen volume and sperm motility, respectively.

As mentioned previously, V89L, A49T and R227Q are three special mutations that alter other amino acids of SRD5A2 among the 648 SNPs detected in the SRD5A2 gene according to public genome databases. The V89L (rs523349) polymorphism has been extensively examined in relation to prostate cancer (24). Although certain studies have shown an association with prostate disease, the results are conflicting (25–27). As yet, there are no conclusions on whether V89L mutation is associated with the risk of prostate cancer (15,28), and there is no conclusive evidence of V89L polymorphism affecting serum hormone levels (25). Our study suggests that there is no association between rs523349 and semen quality. Concerning the A49T and R227Q mutations, they are not captured by tagSNP selection due to their very low frequency.

In their study, Elzanaty et al investigated the effect of SRD5A2 polymorphisms on sperm parameters in Swedish military conscripts. Their results showed that variants of A49T and V89L are associated with sperm concentration and motility, respectively (29). Our results are not in agreement with those authors in that the mutation at rs632148 demonstrated an association with sperm motility, but not the rs523349 (V89L) mutation. This discrepancy may be due to ethnic differences. Another study investigating the effect of SRD5A2 polymorphisms on male infertility in an Estonian population has shown that the SRD5A2 polymorphism exhibited a significant association with sperm motility in normozoospermic men, while no correlation was found between any tagSNP in SRD5A2 and the sperm number (30). Our results are generally consistent with that finding.

SRD5A2 is expressed in the adult epididymis (31), the prostate (32), the male external genitalia, seminal vesicles (33) and intact seminiferous tubules (23). Spermatogenesis and spermatozoa maturation are androgen-dependent processes (4–5,23). DHT is the main androgen responsible for spermatozoan maturation in the epididymis (34) and maintenance of normal spermatogenesis in the testis (23), as well as maintenance of normal function of the prostate and seminal vesicles (35). SRD5A is a key enzyme converting testosterone into DHT. Thus the activity of SRD5A2 may be associated with sperm motility, seminal volume and even sperm count.

In our study, the heterozygote at rs13395648 was significantly associated with semen volume. A possible explanation for this finding is that SRD5A2 activity affected by mutation leads to a reduction of DHT in the microenvironment of the sexual gland and accessory sexual gland, and causes seminal plasma secretion to be reduced.

Additionally, the heterozygote at rs632148 was significantly associated with sperm motility. Sperm progressive motility is necessary for the transit of spermatozoa through the female genital tract and fertilizing ova after ejaculation in the natural process of pregnancy. The epididymis performs is important in the maturation of spermatozoa, including their acquisition of progressive motility and fertilizing ability (36). DHT is the main androgen responsible for spermatozoan maturation in the epididymis (34). Seminal DHT is of primarily epididymal origin (37). Thus, the activity of SRD5A2 may be associated with sperm motility. A study in rats on epididymal sperm maturation has shown that the number of motile sperm is reduced following treatment with dual 5α-reductase inhibitor (38). This indicates the association between SRD5A2 activity and sperm motility.

The majority of the male pseudohermaphrodites with inherited SRD5A2 enzyme deficiency, and thereby decreased DHT production, have shown a low total sperm count, although a few of them maintain normal sperm concentration and motility (39). The A49T mutation was associated with a significantly higher sperm concentration (29). Both of these findings indicate the role of SRD5A2 on spermatogenesis. However, we found no association between any studied polymorphism and sperm number or concentration. This observation may be explained by the fact that lower enzyme activities moderately altered by the SRD5A2 polymorphisms studied may be sufficient for normal spermatogenesis (30), although they affected semen parameters dependent on prostate or epididymis functions, such as semen volume or sperm motility.

A previous study on finasteride and dutasteride revealed a small but significant reduction in semen volume and sperm motility in normal men during treatment and follow-up (40), indicating a role of SRD5A2 activity in producing seminal plasma and gaining sperm motility. Nevertheless, the SRD5A2 polymorphisms have shown an association with seminal volume and sperm motility in Han-Chinese populations with definite idiopathic infertility in our study. However, our results should be interpreted with caution since there is no clear mechanism explaining the differentiation of SRD5A2 expression in the testis, epididymis, prostate and other reproductive tissue, as well as how genetic variants associated with moderately altered enzyme activity or intronic polymorphisms with unknown function would affect semen quality.

We did not collect data to analyze reproductive hormones, but results of the studies by Elzanaty et al and Peters et al did not show any correlation between SRD5A2 allelic variants and the serum levels of reproductive hormones (29,30). Moreover, the treatment of healthy men with 5α-reductase inhibitors did not cause significant changes in their serum gonadotropin levels (40). Thus, it is supposed that the studied polymorphisms or 5α-reductase inhibitors affect the concentrations of DHT in the microenvironment but not in the serum, and are unlikely to affect the serum levels of other reproductive hormones.

In conclusion, this study, to the best of our knowledge, is the first to examine the association of SRD5A2 genetic variants with semen quality in a Han-Chinese population with idiopathic male infertility. Our data suggest that the SRD5A2 genetic variants rs13395648 and rs642138 are associated with seminal volume and sperm motility, respectively. The discrepancies in semen quality characteristics between the genotypes of some variants remain unclear. Thus, larger sample size studies and in vivo or in vitro functional studies are required to confirm the findings of this study.

 Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (grant no. 30973199) and the National Eleventh-Five Science and Technology Support Program of China (grant no. 2006BAI03B12).

 References KrauszCFortiGClinical aspects of male infertilityResults Probl Cell Differ281212000 HuynhTMollardRTrounsonASelected genetic factors associated with male infertilityHum Reprod Update81831982002 JamsaiDReillyASmithSJPolymorphisms in the human cysteine-rich secretory protein 2 (CRISP2) gene in Australian menHum Reprod23215121592008 MooreHDAkhondiMAIn vitro maturation of mammalian spermatozoaRev Reprod154601996 VigerRSRobaireBSteady state steroid 5 alpha-reductase messenger ribonucleic acid levels and immunocytochemical localization of the type 1 protein in the rat testis during postnatal developmentEndocrinology136540954151995 SteinbergerEHormonal control of mammalian spermatogenesisPhysiol Rev511221971 SultanCLumbrosoSParisFDisorders of androgen actionSemin Reprod Med202172282002 MakridakisNMdi SalleEReichardtJKBiochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type IIPharmacogenetics104074132000 DebesJDTindallDJMechanisms of androgen-refractory prostate cancerN Engl J Med351148814902004 CanSZhuYSCaiLQThe identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindredJ Clin Endocrinol Metab835605691998 Fernandez-CancioMNistalMGraciaRCompound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese originJ Androl254124162004 ChavezBValdezEVilchisFUniparental disomy in steroid 5alpha-reductase 2 deficiencyJ Clin Endocrinol Metab85314731502000 MakridakisNRossRKPikeMCA prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductaseCancer Res57102010221997 AllenNEForrestMSKeyTJThe association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in menCancer Epidemiol Biomarkers Prev101851892001 HayesVMSeveriGPadillaEJ5alpha-reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopeciaInt J Cancer1207767802007 MakridakisNMRossRKPikeMCAssociation of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USALancet3549759781999 RossRKPikeMCCoetzeeGAAndrogen metabolism and prostate cancer: establishing a model of genetic susceptibilityCancer Res58449745041998 JiGGuAXiaYERCC1 and ERCC2 polymorphisms and risk of idiopathic azoospermia in a Chinese populationReprod Biomed Online1736412008 OsborneECLynchMMcLachlanRTrounsonAOCramDSMicroarray detection of Y chromosome deletions associated with male infertilityReprod Biomed Online156736802007 LarsenLScheikeTJensenTKComputer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study TeamHum Reprod15156215672000 BarrettJCFryBMallerJDalyMJHaploview: analysis and visualization of LD and haplotype mapsBioinformatics212632652005 MenkveldRWongWYLombardCJSemen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholdsHum Reprod16116511712001 PayneAHKawanoAJaffeRBFormation of dihydrotestosterone and other 5 alpha-reduced metabolites by isolated seminiferous tubules and suspension of interstitial cells in a human testisJ Clin Endocrinol Metab374484531973 LindstromSAdamiHOBalterKAInherited variation in hormone-regulating genes and prostate cancer survivalClin Cancer Res13515651612007 NtaisCPolycarpouAIoannidisJPSRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysisCancer Epidemiol Biomarkers Prev126186242003 CicekMSContiDVCurranAAssociation of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the ARProstate5969762004 SalamMTUrsinGSkinnerECDessissaTReichardtJKAssociations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancerUrol Oncol232462532005 PearceCLMakridakisNMRossRKSteroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population studyCancer Epidemiol Biomarkers Prev114174182002 ElzanatySGiwercmanYLGiwercmanASignificant impact of 5alpha-reductase type 2 polymorphisms on sperm concentration and motilityInt J Androl294144202006 PetersMSaareMKaartTAnalysis of polymorphisms in the SRD5A2 gene and semen parameters in Estonian menJ Androl313723782010 MahonyMCSwanlundDJBilleterMRobertsKPPryorJLRegional distribution of 5alpha-reductase type 1 and type 2 mRNA along the human epididymisFertil Steril69111611211998 BerthautIMestayerCPortoisMCCussenotOMowszowiczIPharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in cultureProstate321551631997 ThigpenAESilverRIGuileyardoJMCaseyMLMcConnellJDRussellDWTissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expressionJ Clin Invest929039101993 RobaireBVigerRSRegulation of epididymal epithelial cell functionsBiol Reprod522262361995 MahendrooMSCalaKMHessDLRussellDWUnexpected virilization in male mice lacking steroid 5 alpha-reductase enzymesEndocrinology142465246622001 CornwallGANew insights into epididymal biology and functionHum Reprod Update152132272009 AndersonRAKellyRWWuFCComparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosteroneJ Androl183663711997 HendersonNARobaireBEffects of PNU157706, a dual 5alpha-reductase inhibitor, on rat epididymal sperm maturation and fertilityBiol Reprod724364432005 CaiLQFratianniCMGautierTImperato-McGinleyJDihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiencyJ Clin Endocrinol Metab794094141994 AmoryJKWangCSwerdloffRSThe effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy menJ Clin Endocrinol Metab92165916652007

Overview of selected tagSNPs and their characteristics. (A) Location of the 5 tagSNPs within the SRD5A2 gene. The plot was generated by Haploview 4.0 software and a confidence intervals algorithm. (B) The 5 tagSNPs and SNPs that are indirectly measured by them are listed with corresponding r2 values. TaqSNP, tagging single-nucleotide polymorphisms; MAF, minor allele frequency.

Association between the selected individual characteristics and sperm parameters in 708 males with definite idiopathic infertility.

N (%) Semen volume (ml) Concentrationa Sperm number per ejaculatea Motility (%)
Age (years)
 <28 224 (31.64) 3.76±1.53 3.50±1.23 4.62±1.31 52.32±24.50
 28–32 216 (30.51) 3.41±1.42 3.65±1.16 4.79±1.28 53.52±22.94
 ≥32 268 (37.85) 3.45±1.33 3.72±1.13 4.89±1.24 49.23±25.21
Smoking
 Yes (ever) 364 (51.41) 3.35±1.36 3.57±1.22 4.71±1.33 51.99±24.00
 No (never) 344 (48.59) 3.49±1.49 3.68±1.13 4.85±1.23 51.01±24.74
Drinking
 Yes (ever) 324 (45.76) 3.38±1.43 3.55±1.23 4.69±1.36b 49.49±24.88b
 No (never) 384 (54.24) 3.45±1.42 3.69±1.13 4.85±1.20 53.23±23.78
BMI
 <20 82 (11.58) 3.23±1.40 3.46±1.25 4.57±1.32 51.78±24.56
 20–25 396 (55.93) 3.39±1.36 3.60±1.20 4.74±1.31 50.72±24.86
 ≥25 230 (32.49) 3.52±1.53 3.73±1.10 4.91±1.19 52.79±23.41
Abs (days)
 <4 176 (24.86) 2.91±1.09 3.50±1.11 4.51±1.17 53.69±22.69
 4–7 357 (50.42) 3.52±1.51c 3.60±1.15 4.76±1.28c 51.20±24.44
 ≥7 175 (24.72) 3.72±1.41c 3.82±1.29c 5.09±1.33c 49.97±25.71

Values are the means ± SD unless otherwise stated. BMI, body mass index; Abs, the duration of sexual abstinence.

Values were re-transformed following logarithmic transformation.

P<0.05 compared to the groups of drinking status.

P<0.05 compared the group of abstinence time <4 days.

Sperm parameters according to the genetic variants of the SRD5A2 gene in 708 males with definite idiopathic infertility.

Variant Genotype N (%) Semen volume (ml) Concentrationa Sperm number per ejaculatea Motility (%)
rs4952197
GG 228 (32.20) 3.40±1.45 3.63±1.11 4.78±1.23 52.75±25.27
GA 340 (48.02) 3.40±1.41 3.66±1.20 4.80±1.29 51.57±24.38
AA 140 (19.77) 3.47±1.42 3.54±1.23 4.70±1.33 49.38±22.71
GA+AA 480 (67.80) 3.42±1.41 3.63±1.21 4.77±1.30 50.93±23.90
rs2268797
CC 299 (42.65) 3.37±1.37 3.55±1.21 4.69±1.30 50.86±23.58
CT 301 (42.94) 3.41±1.38 3.69±1.14 4.85±1.24 51.15±24.85
TT 101 (14.41) 3.51±1.66 3.65±1.18 4.79±1.33 54.15±25.25
CT+TT 402 (57.35) 3.44±1.45 3.68±1.15 4.83±1.26 51.91±24.95
rs13395648
TT 583 (84.01) 3.46±1.44 3.62±1.19 4.78±1.30 51.88±24.40
TC 97 (13.98) 3.07±1.32b 3.62±1.10 4.68±1.16 49.78±25.36
CC 14 (2.20) 3.34±1.09 3.38±1.26 4.54±1.29 56.22±16.00
TC+CC 111 (15.99) 3.10±1.29c 3.60±1.12 4.66±1.17 50.60±24.42
rs523349
CC 133 (19.44) 3.29±1.52 3.68±1.13 4.77±1.24 53.17±25.27
CG 275 (40.20) 3.47±1.36 3.58±1.14 4.75±1.26 49.45±24.51
GG 276 (40.35) 3.42±1.38 3.65±1.22 4.80±1.32 51.81±23.79
CG+GG 551 (80.56) 3.44±1.37 3.61±1.19 4.78±1.29 50.63±24.16
rs632148
GG 132 (18.88) 3.27±1.34 3.70±1.10 4.80±1.20 55.60±24.29
GC 307 (43.92) 3.50±1.49 3.61±1.16 4.79±1.26 49.47±24.82d
CC 260 (37.20) 3.39±1.39 3.62±1.23 4.77±1.33 52.32±23.73e
GC+CC 567 (81.12) 3.45±1.44 3.62±1.19 4.78±1.29 50.78±24.35f

P-values were adjusted for age, smoking, drinking, body mass index (BMI) and the duration of sexual abstinence (Abs). Values are the means ± SD unless otherwise stated.

Values are re-transformed following logarithmic transformation.

P<0.05 compared to rs13395648 TC and TT genotypes (P=0.016).

P<0.05 compared to rs13395648 TC + CC and TT genotypes (P=0.020).

P<0.05 compared to rs632148 GC and GG genotypes (P=0.029).

P=0.078 compared to rs632148 CC and GG genotypes.

P<0.05 compared to rs632148 GC + CC and GG genotypes (P=0.033).